Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Polycystic Ovary Syndrome × Treatment Expectations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Liver Transplantation 1

Interventions

Metformin 74 Clomiphene 27 Letrozole 18 Inositol 18 Chorionic Gonadotropin 11 Folic Acid 10 Exercise 9 drospirenone and ethinyl estradiol combination 8 High-Intensity Interval Training 8 Cholecalciferol 8 cetrorelix 7 Tablets 7 Ethinyl Estradiol 7 Contraceptives, Oral 7 Progesterone 6 Menotropins 6 follitropin alfa 5 Pioglitazone 5 Exenatide 5 Caloric Restriction 5 Triptorelin Pamoate 4 Spironolactone 4 Liraglutide 4 Glycoprotein Hormones, alpha Subunit 4 Diet 4 Cyproterone Acetate 4 follitropin beta 3 Vitamin D 3 Thioctic Acid 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02491320 2021-06-23

PCOSAPct

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡